explore -WSS

explore

author：leisure time 2025-09-29 22:53:08 - browse：994

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Congress likely to miss an opportunity to fix drug shortages issue

WSS

Congress: Eradicate hepatitis C and reduce the deficit

How redistricting in 6 states could affect who controls Congress

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

Involuntary treatment for addiction doesn't work

US intelligence assessment says Iran not currently developing nuclear weapons

hotspot

explore

entertainment

Walensky prepares to leave CDC — and Congress — behind

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Europe sees delivery challenges ahead on Alzheimer's therapies

Medicare details structure of new drug price negotiation program

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

Alkermes shareholders re

Another man arrested in connection with shooting at Kansas nightclub

Virginia high school admissions case could be legal follow

Eli Lilly to acquire Versanis in heated race for weight loss drugs

entertainment

Sen. Bill Cassidy on how to lower drug prices

Why Titanic fascinates society, still drawing tours to the wreckage

How redistricting in 6 states could affect who controls Congress

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

explore

leisure time

Wikipedia

hotspot